ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HOTH Hoth Therapeutics Inc

1.47
0.09 (6.52%)
After Hours
Last Updated: 18:11:40
Delayed by 15 minutes

Period:

Draw Mode:

Volume 254,519
Bid Price 1.46
Ask Price 1.53
News -
Day High 1.52

Low
0.99

52 Week Range

High
4.30

Day Low 1.3607
Company Name Stock Ticker Symbol Market Type
Hoth Therapeutics Inc HOTH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.09 6.52% 1.47 18:11:40
Open Price Low Price High Price Close Price Prev Close
1.40 1.3607 1.52 1.52 1.38
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
863 254,519 $ 1.46 $ 370,370 - 0.99 - 4.30
Last Trade Time Type Quantity Stock Price Currency
17:36:19 formt 407 $ 1.47 USD

Hoth Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.56M 4.35M - 0 -11.37M -2.62 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Hoth Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HOTH Message Board. Create One! See More Posts on HOTH Message Board See More Message Board Posts

Historical HOTH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.371.651.301.43875,1200.107.30%
1 Month1.271.671.151.371,270,1570.2015.75%
3 Months1.451.691.151.36513,6210.021.38%
6 Months1.541.730.991.40355,922-0.07-4.55%
1 Year2.184.300.992.64696,350-0.71-32.57%
3 Years51.7555.000.9922.451,439,409-50.28-97.16%
5 Years128.75226.750.9934.921,227,549-127.28-98.86%

Hoth Therapeutics Description

Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.

Your Recent History

Delayed Upgrade Clock